[1]
“Financial health overview of pharmaceutical sector companies listed on IDX using profitability ratios before, during, and after the COVID-19 pandemic”, JBM, vol. 6, no. 1, pp. 310–317, Jan. 2026, doi: 10.60036/jbm.1034.